| Client Successes |
Driving Biopharma Forward
Our lawyers identified, on the eve of FDA approval of one of our client's biopharmaceuticals, a prior public use that would cause a court to invalidate the otherwise blocking patent claims. This enabled our client to negotiate a license under the patent on commercially reasonable terms.
|
Due Diligence Across the World
We were retained by one of the world's largest pharmaceutical companies to join a team of in-house management-level scientific and business decision-makers on an IP due-diligence trip to eastern Europe. The team vetted the potential licensor's patent and trade-secret portfolios, and also considered potential associated regulatory and logistical issues.
|
Harvard University and Massachusetts Institute of Technology
Our lawyers have been retained by Harvard University and Massachusetts Institute of Technology in several projects, and have obtained worldwide patent protection for numerous pioneering inventions in organic chemistry and chemical engineering. For example, we have obtained for the institutions domestic and foreign patents protecting asymmetric transition-metal-catalyzed reductions; asymmetric transition-metal-catalyzed cycloadditions; and transition-metal-catalyzed carbon-heteroatom and carbon-carbon bond-forming reactions.
|
First
Previous
1
Next
Last